hGH fragment comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-08. Numbers and descriptions here follow the published literature rather than marketing material.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Governor Gavin Newsom official government website Gavin Newsom on Twitter official personal Twitter account Office of the Governor of California official governor Twitter account Gavin Newsom for Governor campaign website CityMayors profile about Gavin Newsom Profile at Vote Smart Appearances on C-SPAN Gavin Newsom at On the Issues
== Further reading == Angeli S, Ceron F, Scaloni A, Monti M, Monteforti G, Minnocci A, et al. (1999). "Purification, structural characterization, cloning and immunocytochemical localization of chemoreception proteins from Schistocerca gregaria". Eur J Biochem. 262 (3): 745–54. doi:10.1046/j.1432-1327.1999.00438.x. PMID 10411636.
Seventeen isotopes of mendelevium are known, with mass numbers from 244 to 260; all are radioactive. The longest-lived isotope is 258Md with a half-life of 51.6 days. Nevertheless, the shorter-lived 256Md (half-life 77.7 minutes) is more often used in chemical experiments because it can be produced in larger quantities from einsteinium, as 258Md would require 255Es, of which significant quantities are available only as a minor component of an isotopic mixture. The half-lives of mendelevium isotopes mostly increase smoothly (apart from odd/even effects) toward higher mass, up to 258Md, then decrease (as indicated by what experimental data is available) as spontaneous fission becomes the dominant decay mode; the second longest-living isotope is 260Md, the heaviest known, with a half-life of 27.8 days. Mendelevium is the last element that has any known isotope with a half-life longer than a day. Mendelevium-256, the currently most important isotope of mendelevium, decays about 90% through electron capture and 10% through alpha decay. It is most easily detected through the spontaneous fission of its electron capture daughter fermium-256, but in the presence of other nuclides that undergo spontaneous fission, alpha decays at the characteristic energies for mendelevium-256 (7.205 and 7.139 MeV) can provide more useful identification.
Flying Officer (now Acting Wing Commander) Robert Charles Timothy, Royal Air Force, 30389992. Civil Enass Abo Hamed. Co-Founder and Chief Executive Officer, H2GO Power. For services to Engineering and to Enterprise. Dr. Helen Mary Abrahams (Helen Pain). Chief Executive, Royal Society of Chemistry and lately Chair, Board of Trustees, Science Council. For services to Science. Sheila Ann Abrahams. Founder, Freelance Hairdressers' Association. For services to the Hairdressing Industry. Gerald Ronald Joseph Adams. For voluntary services to the community in Barry, Glamorgan. Bayo Adelaja. Founder and Chief Executive Officer, Do It Now Now. For services to Social Mobility, to Financial Inclusion and to Entrepreneurship. Dr. Olurotimi Babatunde Adesanya. Founder and Chair, African and Caribbean Dental Association UK and Principal Dentist, Watling Street Dental Care. For services to Oral Health. Taslima Parveen Ahmad. Founder, Creative Design and Manufacture UK. For services to Disadvantaged People and to the Minority Ethnic Community. Shabnam Ahmed Butt. Lead for Adult Safeguarding, Camden London Borough Council. For services to Social Care. Jill Alcock (Jill Clewes). Founder, Jill Clewes Academy for Theatre Arts. For services to the Arts and to Charity. Michael Allen. Principal, Lisneal College. For services to Education. Ethel Gloria Anderson. For services to the community in St Ann's, Nottingham. Samuel James Anderson. Founder and Chief Executive, IceMOS Technology. For services to Economic Development in Northern Ireland. Colin Trevor Whitney Angel.
== Personal life and death == French met Patricia Anne "Pat" Soule while attending Pasadena City College, and the two married in June 1950. They were married for 66 years, until her death in February 2017, and had two children. Pat worked as an acting teacher at Bellevue College and later worked with her husband on Imagination Theatre. French died in Seattle on December 20, 2017, at age 89.
Sources: en.wikipedia.org
==== Weight training and other types of physical activity cause baldness ==== Because it increases testosterone levels, many Internet forums have put forward the idea that weight training and other forms of exercise increase hair loss in predisposed individuals. Although scientific studies do support a correlation between exercise and testosterone, no direct study has found a link between exercise and baldness. However, a few have found a relationship between a sedentary life and baldness, suggesting exercise is causally relevant. The type or quantity of exercise may influence hair loss. Testosterone levels are not a good marker of baldness, and many studies actually show paradoxical low testosterone in balding persons, although research on the implications is limited.
== Professional and political career == He was into real estate business on large scale in and around Hyderabad. He was a successful businessman and was paying IT returns of 9 lakhs and 12 lakhs per annum in 2012–13 and 2013–14. He does not have any criminal cases pending against him as of 2014. After the reconstitution of constituencies in 2009 and subsequent defeat of TDP in Repalle, probable retirement of Mummaneni Venkata Subbaih (Then TDP candidate) brought Anagani Satya Prasad into the political arena. The decision of TDP to allot 100 seats to BCs then was an enabling factor for him. In 2009 he contested the elections but lost. But he emerged victorious in the 2014 and 2019 elections.
=== Detection in body fluids === Reviews that cover attention deficit hyperactivity disorder (ADHD) and phenethylamine indicate that several studies have found abnormally low urinary phenethylamine concentrations in ADHD individuals when compared with controls. In treatment-responsive individuals, amphetamine and methylphenidate greatly increase urinary phenethylamine concentration. An ADHD biomarker review also indicated that urinary phenethylamine levels could be a diagnostic biomarker for ADHD. Thirty minutes of moderate- to high-intensity physical exercise has been shown to induce an increase in urinary phenylacetic acid, the primary metabolite of phenethylamine. Two reviews noted a study where the mean 24 hour urinary phenylacetic acid concentration following just 30 minutes of intense exercise rose 77% above its base level; the reviews suggest that phenethylamine synthesis sharply increases during physical exercise during which it is rapidly metabolized due to its short half-life of roughly 30 seconds. In a resting state, phenethylamine is synthesized in catecholamine neurons from L-phenylalanine by aromatic amino acid decarboxylase at approximately the same rate as dopamine is produced. Monoamine oxidase deaminates primary and secondary amines that are free in the neuronal cytoplasm but not those bound in storage vesicles of the sympathetic neurone. Similarly, β-PEA would not be completely deaminated in the gut as it is a selective substrate for MAO-B, which is not primarily found in the gut.
== Pharmacology == Dihydromorphine acts as an agonist at the μ-opioid with a Ki value of 2.5 nM compared to 4.9 nM of morphine, δ-opioid with a Ki value of 137 nM compared to 273 nM of morphine and κ-opioid with a Ki value of 223 nM compared to 227 nM of morphine. Dihydromorphine is therefore slightly more μ-selective than morphine. Agonism of the μ-opioid and δ-opioid receptors is largely responsible for the clinical effects of opioids like dihydromorphine, with the μ-agonism providing more analgesia than the δ.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.